Myriad Genetics Inc (MYGN)

Operating profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating income	US$ in thousands	-88,000	-257,400	-123,700	-48,700	-194,800
Revenue	US$ in thousands	837,600	753,200	678,400	690,600	557,000
Operating profit margin		-10.51%	-34.17%	-18.23%	-7.05%	-34.97%

December 31, 2024 calculation

Operating profit margin = Operating income ÷ Revenue
= $-88,000K ÷ $837,600K
= -10.51%

Based on the provided data, Myriad Genetics Inc has shown fluctuating trends in its operating profit margin over the past five years. The operating profit margin, which indicates the percentage of revenue remaining after deducting operating expenses, was at -34.97% as of December 31, 2020. This negative margin suggests that the company's operating expenses exceeded its operating income, resulting in a loss.

In the following year, the operating profit margin improved to -7.05% as of December 31, 2021, indicating a reduction in the proportion of operating expenses relative to revenue. However, the margin deteriorated in the subsequent year to -18.23% as of December 31, 2022, suggesting that operating expenses increased disproportionately compared to revenue.

By December 31, 2023, the operating profit margin further decreased to -34.17%, reflecting a significant decline in operational efficiency and profitability. However, there was a slight recovery in the operating profit margin to -10.51% as of December 31, 2024, indicating some improvement in managing operating expenses relative to revenue.

Overall, the trend in Myriad Genetics Inc's operating profit margin has been turbulent, with periods of both improvement and deterioration. It is essential for the company to focus on optimizing operational efficiency, controlling costs, and enhancing revenue generation to achieve sustainable profitability in the future.